Cellebrite DI (CLBT) Equity Average (2022 - 2025)

Cellebrite DI's Equity Average history runs 4 years deep, the most recent figure standing at $466.0 million for Q4 2025.

• In Q4 2025, Equity Average rose 46.93% year-over-year to $466.0 million; the TTM figure through Dec 2025 stood at $466.0 million (up 46.93% YoY), while the FY2025 annual figure was $410.2 million, up 121.57% from the prior year.
• Equity Average was $466.0 million for Q4 2025 at Cellebrite DI, up from $428.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $466.0 million in Q4 2025 to a low of -$42.8 million in Q1 2022.
• Historically, Equity Average has averaged $187.0 million across 4 years, with a median of $56.6 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Equity Average plunged 93.37% in 2024, then jumped 9219.4% in 2025.
• A 4-year view of Equity Average shows it stood at -$42.8 million in 2022, then surged by 184.32% to $36.1 million in 2023, then soared by 779.14% to $317.2 million in 2024, then surged by 46.93% to $466.0 million in 2025.
• The last three Equity Average figures came in at $466.0 million (Q4 2025), $428.0 million (Q3 2025), and $386.0 million (Q2 2025), per Business Quant data.